NCT03030105: Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers |
|
|
| Completed | 1 | 38 | US | BPN14770, BPN14770 placebo, Donepezil, Aricept, Donepezil placebo, Aricept placebo, Scopolamine 0.6 MG/ML, Hyoscine s.c., Scopolamine placebo, Hyoscine s.c. placebo | Tetra Discovery Partners | Alzheimer Disease | 05/17 | 06/17 | | |